The store will not work correctly when cookies are disabled.
H9,H9a-trans-2,3,4,4a,9,9a-Hexahydro-9-phenyl-1H-indeno[2,1-c]pyridine Hydrochloride
ID: ALA3249180
PubChem CID: 90673618
Max Phase: Preclinical
Molecular Formula: C18H20ClN
Molecular Weight: 249.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.c1ccc([C@H]2c3ccccc3[C@@H]3CCNC[C@H]23)cc1
Standard InChI: InChI=1S/C18H19N.ClH/c1-2-6-13(7-3-1)18-16-9-5-4-8-14(16)15-10-11-19-12-17(15)18;/h1-9,15,17-19H,10-12H2;1H/t15-,17-,18-;/m0./s1
Standard InChI Key: RSNYWIOXFIDPPP-OOAIBONUSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.7983 -18.2112 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.8614 -17.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1548 -17.0868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1570 -16.2696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8658 -15.8629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5724 -16.2734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5702 -17.0906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3769 -17.3372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8984 -16.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0859 -16.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7555 -15.8398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2376 -15.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0501 -15.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3805 -16.0150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1223 -18.1137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3225 -18.2815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0679 -19.0580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6131 -19.6668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4129 -19.4990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6675 -18.7225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1506 -15.4523 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
12.1506 -17.9039 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
2 7 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
3 8 1 0
4 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
8 15 1 1
4 21 1 1
3 22 1 1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.36 | Molecular Weight (Monoisotopic): 249.1517 | AlogP: 3.53 | #Rotatable Bonds: 1 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.23 | CX LogP: 3.47 | CX LogD: 0.78 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.82 | Np Likeness Score: 0.35 |
References
1. Ellefson CR, Woo CM, Cusic JW.. (1978) Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives., 21 (4): [PMID:650662] [10.1021/jm00202a005] |